Astrana Health, Inc. (ASTH)
37.45
-0.56
(-1.47%)
USD |
NASDAQ |
Oct 23, 16:00
37.45
0.00 (0.00%)
Pre-Market: 20:00
Astrana Health Enterprise Value : 2.189B for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 2.189B |
| October 22, 2026 | 2.217B |
| October 21, 2026 | 2.184B |
| October 20, 2026 | 2.245B |
| October 19, 2026 | 2.162B |
| October 16, 2026 | 2.158B |
| October 15, 2026 | 2.218B |
| October 14, 2026 | 2.202B |
| October 13, 2026 | 2.210B |
| October 12, 2026 | 2.236B |
| October 09, 2026 | 2.194B |
| October 08, 2026 | 2.111B |
| October 07, 2026 | 2.174B |
| October 06, 2026 | 2.167B |
| October 05, 2026 | 2.158B |
| October 02, 2026 | 2.112B |
| October 01, 2026 | 2.064B |
| September 30, 2026 | 2.097B |
| September 29, 2026 | 2.091B |
| September 28, 2026 | 2.075B |
| September 25, 2026 | 2.136B |
| September 24, 2026 | 2.041B |
| September 23, 2026 | 2.036B |
| September 22, 2026 | 2.074B |
| September 21, 2026 | 1.997B |
| Date | Value |
|---|---|
| September 18, 2026 | 2.037B |
| September 17, 2026 | 2.034B |
| September 16, 2026 | 2.201B |
| September 15, 2026 | 2.233B |
| September 14, 2026 | 2.295B |
| September 11, 2026 | 2.215B |
| September 10, 2026 | 2.218B |
| September 09, 2026 | 2.219B |
| September 08, 2026 | 2.221B |
| September 04, 2026 | 2.239B |
| September 03, 2026 | 2.208B |
| September 02, 2026 | 2.244B |
| September 01, 2026 | 2.246B |
| August 31, 2026 | 2.222B |
| August 28, 2026 | 2.214B |
| August 27, 2026 | 2.236B |
| August 26, 2026 | 2.246B |
| August 25, 2026 | 2.197B |
| August 24, 2026 | 2.222B |
| August 21, 2026 | 2.283B |
| August 20, 2026 | 2.253B |
| August 19, 2026 | 2.285B |
| August 18, 2026 | 2.273B |
| August 17, 2026 | 2.302B |
| August 14, 2026 | 2.355B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Agilon Health, Inc. | 1.282B |
| Starling Oncology, Inc. | 737.53M |
| Nakamoto, Inc. | 277.34M |
| American Oncology Network, Inc. | -- |
| Regional Health Properties, Inc. | 61.12M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 18.45M |
| Revenue (Quarterly) | 972.52M |
| Total Expenses (Quarterly) | 952.78M |
| EPS Diluted (Quarterly) | 0.3965 |
| Gross Profit Margin (Quarterly) | 9.10% |
| Profit Margin (Quarterly) | 1.90% |
| Earnings Yield | 2.19% |
| Operating Earnings Yield | 5.42% |
| Normalized Earnings Yield | 1.971 |